
Holly Kordasiewicz, Ph.D.
VP of Neurology Research
Ionis Pharmaceuticals
Dr. Holly Kordasiewicz has spent her whole career in the pursuit of understanding neurodegenerative diseases; she is passionate about the progress she and her team at Ionis are making in their research using antisense oligonucleotide therapeutics to treat ALS, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other gene-based diseases with unmet needs.